Arquer Diagnostics to Bolster Study Data Supporting Bladder Cancer Test
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Read MorePosted by Elaine Sanchez Wilson | Feb 2, 2016 | Research |
The company recently received ethical approval to commence a 6-month clinical study using its urine test for cancer.
Read MorePosted by Elaine Sanchez Wilson | Jan 19, 2016 | Cancer, Unknown Origin & Other Cancer Types |
In this month’s Inside Track, Nadia Altomare, CEO of Abcodia, discusses how her company’s test can lead to improved clinical outcomes.
Read MorePosted by Steve Halasey | Dec 8, 2015 | Research |
Study will test the effectiveness of a high-sensitivity ELISA test for screening and detecting recurrence of bladder cancer.
Read MorePosted by Elaine Sanchez Wilson | Oct 30, 2015 | Cancer, Molecular Diagnostics |
Quantitative tissue-based diagnostics are advancing the promise of personalized medicine.
Read MorePosted by Steve Halasey | Sep 28, 2015 | Research |
Clinical data show the utility of Biocept’s liquid biopsy assay in therapeutic management of patients with non-small cell lung cancer.
Read More